Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA accepts Akesis’ diabetic drug IND
DGD Research of San Antonio has begun screening patients in a Phase IIa, controlled US clinical trial measuring efficacy (using the gold-standard euglycemic-hyperinsulinemic clamping procedure), as well as
DGD Research of San Antonio has begun screening patients in a Phase IIa, controlled US clinical trial measuring efficacy (using the gold-standard euglycemic-hyperinsulinemic clamping procedure), as well as
Fentora supplemental new drug application (sNDA) includes data from three randomized, placebo-controlled clinical trials and one long-term open-label safety study with a total of 941 opioid tolerant patients.
This Phase II (Beneficial study) trial is designed to measure the effect of alagebrium on exercise tolerance in patients with chronic heart failure (CHF). The single-site Phase II
In this study, patients with either advanced solid tumors or non-Hodgkin’s lymphoma (NHL) will receive a three-hour intravenous (IV) infusion of RH1 administered once every 21 days. Patients
As part of the development work under the previous agreement, Alltracel’s healthcare services division was also contracted by ConvaTec to perform laboratory testing and analysis work. The extension
This financing will also be used to conduct preclinical studies, efficacy and toxicity in connection with the company’s efforts to treat and cure Parkinson’s disease and ALS (Lou
Infinity will also have the right to opt-in to certain Hedgehog programs being developed by AstraZeneca, including worldwide profit sharing and US co-promotion rights. In exchange for these
This initial trial is designed to evaluate the safety, tolerability, and pharmacokinetics of LX2931. Lexicon expects to initiate clinical trials with LX2931 following FDA review. Philip Brown, vice
This Phase III trial known as SYMMETRY (synta metastatic melanoma elesclomol trial), is enrolling patients with stage IV metastatic melanoma who have not received prior chemotherapy but who
Cofact is Sanquin’s prothrombin complex of blood factors II, VII, IX and X which is currently in MRP (mutual recognition procedure) registration, in a number of Crucell’s key